Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients

Rachael Tarlinton, Radu Tanasescu, Claire Shannon-Lowe, Bruno Gran
doi: https://doi.org/10.1101/2023.11.10.23298370

Article Information

doi 
https://doi.org/10.1101/2023.11.10.23298370
History 
  • November 10, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Rachael Tarlinton1,*,
  2. Radu Tanasescu2,3,
  3. Claire Shannon-Lowe4 and
  4. Bruno Gran2,3
  1. 1School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom
  2. 2Department of Neurology, Nottingham University Hospitals NHS Trust, Queens Medical Centre, Derby Road, Nottingham, United Kingdom
  3. 3School of Medicine, University of Nottingham, University Park Campus, Nottingham, United Kingdom
  4. 4Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
  1. ↵*corresponding author Rachael.tarlinton{at}nottingham.ac.uk
Back to top
Posted November 10, 2023.
Download PDF
Data/Code
Email
Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients
Rachael Tarlinton, Radu Tanasescu, Claire Shannon-Lowe, Bruno Gran
medRxiv 2023.11.10.23298370; doi: https://doi.org/10.1101/2023.11.10.23298370
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area